Physical Activity, Exercise Capacity and Sedentary Behavior in People with Alpha-1 Antitrypsin Deficiency: A Scoping Review

Physical Activity, Exercise Capacity and Sedentary Behavior in People with Alpha-1 Antitrypsin Deficiency: A Scoping Review

Orlagh O’Shea,1 Saidhbhe Casey,1 Ciaran Giblin,1 Aoife Stephenson,1,2 Tomás P Carroll,3 Noel G McElvaney,3 Suzanne M McDonough1,2,4,5 1School of Physiotherapy, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin 2, Ireland; 2School of Health Sciences, University o...

Full description

Bibliographic Details
Main Authors:	O'Shea O, Casey S, Giblin C, Stephenson A, Carroll TP, McElvaney NG, McDonough SM
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-06-01
Series:	International Journal of COPD
Subjects:	lung disease aatd copd physical activity measurement sedentary behavior exercise capacity
Online Access:	https://www.dovepress.com/physical-activity-exercise-capacity-and-sedentary-behavior-in-people-w-peer-reviewed-fulltext-article-COPD

Similar Items

Risk of lung disease with the Pi*SS genotype of alpha-1 antitrypsin: the evidence in context
by: Helen O’Brien, et al.
Published: (2025-01-01)

Self-administration of augmentation therapy for alpha 1-antitrypsin deficiency
by: A. Vianello, et al.
Published: (2025-01-01)

Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD
by: Ellis P, et al.
Published: (2024-01-01)

Alpha-1-antitrypsin deficiency in children: Clinical characteristics and diagnosis
by: Radlović Nedeljko, et al.
Published: (2014-01-01)

Structural characterization and conformational dynamics of alpha-1 antitrypsin pathogenic variants causing alpha-1-antitrypsin deficiency
by: Noor Ahmad Shaik, et al.
Published: (2022-11-01)

Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency – analysis from the German Registry
by: Bernhard N, et al.
Published: (2017-05-01)

Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease
by: Lorenz Balcar, et al.
Published: (2022-11-01)

Alpha-defensins increase NTHi binding but not engulfment by the macrophages enhancing airway inflammation in Alpha-1 antitrypsin deficiency
by: Jungnam Lee, et al.
Published: (2025-02-01)

Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in alfa-1 anti-trypsin deficiency-related COPD development?
by: Laura Pini, et al.
Published: (2021-06-01)

Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
by: Emanuel Buck, et al.
Published: (2022-01-01)

Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History
by: Simona Viglio, et al.
Published: (2020-09-01)

Shear Wave Elastography and Shear Wave Dispersion Imaging in the Assessment of Liver Disease in Alpha1-Antitrypsin Deficiency
by: Marten Schulz, et al.
Published: (2021-03-01)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
by: Chapman KR, et al.
Published: (2018-01-01)

Transitioning Clinical Data into Patient Care: Recent Real-Life Experiences with Alpha 1
by: Jan Stolk, et al.
Published: (2017-10-01)

Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
by: Chotirmall SH, et al.
Published: (2015-01-01)

NAFLD and AATD Are Two Diseases with Unbalanced Lipid Metabolism: Similarities and Differences
by: Sara Perez-Luz, et al.
Published: (2023-07-01)

Associations between sedentary behaviour and sarcopenia among patients aged 40 and older with chronic obstructive pulmonary disease: a cross-sectional study
by: Dandan Wang, et al.
Published: (2025-01-01)

24-hour accelerometry in COPD: Exploring physical activity, sedentary behavior, sleep and clinical characteristics
by: Orme MW, et al.
Published: (2019-02-01)

The prevalence of alpha-1 antitrypsin deficiency in Ireland
by: Morris Valerie B, et al.
Published: (2011-07-01)

Diagnosing α1-antitrypsin deficiency: how to improve the current algorithm
by: Noel G. McElvaney
Published: (2015-03-01)

Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
by: Chotirmall, Sanjay Haresh, et al.
Published: (2015)

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
by: Dunlea DM, et al.
Published: (2018-03-01)

Using computer, mobile and wearable technology enhanced interventions to reduce sedentary behaviour: a systematic review and meta-analysis
by: Aoife Stephenson, et al.
Published: (2017-08-01)

A rare AAT variant presenting in a COPD patient: Q0 amersfoort mutation
by: Seda Tural Önür, et al.
Published: (2024-01-01)

The “Worktivity” mHealth intervention to reduce sedentary behaviour in the workplace: a feasibility cluster randomised controlled pilot study
by: Aoife Stephenson, et al.
Published: (2021-07-01)

Novel sedentary cage induced sedentariness in rats: evidence from relevant biomarkers
by: Quadri K. Alabi, et al.
Published: (2022-11-01)

Alpha-1 antitrypsin regulates neutrophil reactive oxygen species production via inhibition of key players of the respiratory burst oxidase system
by: Alfawaz Bader, et al.
Published: (2013-01-01)

Comparative Study of Anthropometric and Cardiovascular Parameters in Healthy Sedentary and Non-Sedentary Subjects in the Nnewi Community
by: Ukoha Ukoha, et al.
Published: (2019-01-01)

Associations between Sedentary Time and Sedentary Patterns and Cardiorespiratory Fitness in Chinese Children and Adolescents
by: Ming Li, et al.
Published: (2022-07-01)

Ataluren, a new therapeutic for alpha-1 antitrypsin deficient individuals with nonsense mutations
by: Reeves, E, et al.
Published: (2018)

A study protocol for a randomised controlled feasibility trial of an intervention to increase activity and reduce sedentary behaviour in people with severe mental illness: Walking fOR Health (WORtH) Study
by: Suzanne M. McDonough, et al.
Published: (2021-11-01)

Whole exome sequencing in a juvenile idiopathic arthritis large family with SERPINA1 gene mutations
by: Cyprian Popescu
Published: (2022-07-01)

Sedentariness: A Need for a Definition
by: Valentin Magnon, et al.
Published: (2018-12-01)

C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency
by: Laura T. Fee, et al.
Published: (2021-12-01)

Alpha-defensins inhibit ERK/STAT3 signaling during monocyte-macrophage differentiation and impede macrophage function
by: Jungnam Lee, et al.
Published: (2023-12-01)

Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
by: Barrecheguren M, et al.
Published: (2016-05-01)

Subjective assessment of sedentary behavior between theory and practice: Pilot study using the “Sedentary meter”
by: Ana Cikač, et al.
Published: (2024-12-01)

Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals
by: Padraig Hawkins, et al.
Published: (2021-08-01)

Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency
by: Perotin JM, et al.
Published: (2018-11-01)

Advancing the understanding and treatment of lung pathologies associated with alpha 1 antitrypsin deficiency
by: Alice M. Turner, et al.
Published: (2025-02-01)